BE693186A - - Google Patents
Info
- Publication number
- BE693186A BE693186A BE693186DA BE693186A BE 693186 A BE693186 A BE 693186A BE 693186D A BE693186D A BE 693186DA BE 693186 A BE693186 A BE 693186A
- Authority
- BE
- Belgium
- Prior art keywords
- aspirin
- niacin
- weight
- parts
- per part
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 36
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 35
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 33
- 229960003512 nicotinic acid Drugs 0.000 claims description 32
- 235000001968 nicotinic acid Nutrition 0.000 claims description 32
- 239000011664 nicotinic acid Substances 0.000 claims description 32
- 241001465754 Metazoa Species 0.000 claims description 13
- 206010030113 Oedema Diseases 0.000 claims description 12
- 206010061218 Inflammation Diseases 0.000 claims description 11
- 230000004054 inflammatory process Effects 0.000 claims description 11
- 230000001225 therapeutic effect Effects 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000011287 therapeutic dose Methods 0.000 claims 2
- 241001556567 Acanthamoeba polyphaga mimivirus Species 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000000207 volumetry Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE693186 | 1967-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE693186A true BE693186A (cs) | 1967-07-03 |
Family
ID=3850129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE693186D BE693186A (cs) | 1967-01-25 | 1967-01-25 |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE693186A (cs) |
-
1967
- 1967-01-25 BE BE693186D patent/BE693186A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2703906B2 (ja) | 酸化に対して安定化された薬剤組成物 | |
| US4415576A (en) | Method for preventing body fat deposition in mammals | |
| US4900755A (en) | Controlled release combination of carbidopa/levodopa | |
| JP2852043B2 (ja) | 安定化薬剤組成物 | |
| US4983400A (en) | Controlled release combination of carbidopa/levodopa | |
| FR2914188A1 (fr) | Nouvelle composition a base d'oxime de cholest-4-en-3-one | |
| JPH10512573A (ja) | セスキテルペンラクトンとビタミンｂ複合体とを含む片頭痛およびその他の疾病治療用複合剤 | |
| BE1000381A4 (fr) | Preparation pharmaceutique a base d'indometacine. | |
| US2721161A (en) | Ascorbic acid preparation | |
| US3094464A (en) | Aspirin-antacid polysiloxane tablet | |
| JPWO2002015900A1 (ja) | イブプロフェンカプセル充填液及びカプセル製剤 | |
| EP1178787B1 (fr) | Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation | |
| BE693186A (cs) | ||
| JP3982889B2 (ja) | イブプロフェン含有医薬製剤 | |
| US2910403A (en) | Anti hypertensive compositions comprising 2-methyl-5, 8-dimethoxychromone and acetamides | |
| EP0959892B1 (fr) | Utilisation de pvp ou povidone pour diminuer le gonflement intestinal | |
| JP2891738B2 (ja) | アルコール吸収抑制剤 | |
| BE1004243A3 (fr) | Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation. | |
| EP0775488B1 (fr) | Composition pharmaceutique stable à base d'acide acétylsalicyclique et de tocophérol | |
| JP7229012B2 (ja) | 内服用医薬組成物 | |
| JP7229013B2 (ja) | 内服用医薬組成物 | |
| RU2692930C1 (ru) | Антидотная композиция для лечения при отравлениях метиловым спиртом и этиленгликолем | |
| EP3738596B1 (fr) | Composé et composition pour utilisation dans le traitement du syndrome prémenstruel et/ou du trouble dysphorique prémenstruel | |
| JP2021107330A (ja) | 内服用医薬組成物 | |
| WO2023043392A1 (en) | Use of the extracts of mad honey (rhododendron honey) and rhododendrons as anti-hypertensive |